3 results
Approved WMOCompleted
The co-primary objectives of this study are: * To evaluate the efficacy of as measured by investigator-assessed PFS according to Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST v1.1). * To evaluate the efficacy of atezolizumab as…
Approved WMOWill not start
To assess the safety of cisplatin doublets with hypofractionated radiotherapy (24 x2.75Gy).
Approved WMORecruiting
To compare two (standard) treatment regimens in patients with KRAS mutated advanced stage NSCLC as first line treatment.